ML Strategies
Viewpoints
Filter by:
Health Care Congressional Outlook for the June Work Period
June 6, 2016 | Alert | By Alexander Hecht
The next six weeks are shaping up to be the final work period before the summer recess, with both chambers scheduled to leave DC by July 15th for party conventions followed by the August recess.
Read more
FY2017 Massachusetts Budget Update: The Senate Budget
May 31, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Maxwell Fathy
The Massachusetts Senate voted unanimously to pass its FY2017 state budget just before midnight on Thursday, May 26. The spending plan, which totals $39.558 billion, spends $60 million more than Governor Baker’s proposal and $50 million more than the House plan approved last month.
Read more
FY2017 Massachusetts Budget Update: The House Budget
May 2, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Parnia Zahedi
In a unanimous vote of 156-0, the Massachusetts House of Representatives approved a $39.56 billion spending plan for FY2017 on April 27. Over three days, the House considered more than 1,300 amendments to pass a final budget that allocates approximately $10 million more than Governor Baker’s spending plan, but closely resembles his proposals.
Read more
Governor Baker Signs Controversial Solar Legislation Lifting Solar Energy Caps
April 13, 2016 | Alert
Massachusetts Governor Charlie Baker has signed a solar energy bill into law that increases the statewide limits on the amount of solar capacity that will qualify for net metering, but also lowers the value of net metering credits for large-scale projects.
Read more
Senate HELP Committee Convenes Third and Final Cures Markup
April 6, 2016 | Advisory
This morning the Senate Committee on Health, Education, Labor, and Pensions (HELP) will hold its third and final markup for its biomedical innovations package. This package is a compliment to the House-passed 21st Century Cures Act, which the House passed in July of 2015.
Read more
Health Care Congressional Outlook for the Spring Work Period
April 4, 2016 | Advisory | By Alexander Hecht
The next work period basically runs from April 4 to May 27, with both chambers adjourning for a week long recess the week of May 2. Following this work period, there will be five weeks left on the legislative calendar before Congress recesses for Summer.
Read more
Senate HELP Committee Eyes Mental Health, Substance Use Package
March 16, 2016 | Advisory | By Alexander Hecht
This morning, the Senate HELP Committee will hold an executive session regarding the Mental Health Reform Act of 2016, a comprehensive mental health package negotiated in part by the Senate HELP Committee and the Administration.
Read more
Governor Baker Signs Opioid Bill
March 14, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Sasha Dudding
Today, Massachusetts Governor Charlie Baker signed a bill that offers long-awaited measures aimed at tackling the state’s growing opioid abuse crisis. After receiving House and Senate approval last week and spending seven weeks in conference committee negotiations, the bill will now become law.
Read more
Massachusetts Legislature Reaches Compromise on Opioid Legislation
March 11, 2016 | Alert
On March 10, the Senate voted unanimously to pass a bill that offers long-awaited measures aimed at tackling the state’s growing opioid abuse crisis. After House approval the previous day and seven weeks of conference committee negotiations, the bill is now on the governor’s desk, and is poised to become law.
Read more
Health Care: What's on the Radar for This Congressional Work Period
February 19, 2016 | Advisory | By Alexander Hecht
The next Hill work period basically runs from February 22 to March 18. As Congress returns, here’s a brief look at the pending health care issues on the radar for this work period.
Read more
Deciphering the Final AMP Rule – Key Provisions Impacting Pharmacies, PBMs, and Manufacturers
February 10, 2016 | Advisory | By Theresa Carnegie, Lauren Moldawer
In late January, the Centers for Medicare & Medicaid Services (“CMS”) released the much anticipated Covered Outpatient Drugs Final Rule with Comment (the “AMP Final Rule”).
Read more
Governor Baker Files FY2017 Budget, Economic Development Bill; Speaker DeLeo Outlines Agenda
February 1, 2016 | Alert | By Steven Baddour, Daniel Connelly, Julie Cox, Sasha Dudding, Maxwell Fathy
With Beacon Hill off and running in the new year, Governor Charlie Baker and House Speaker Robert DeLeo this week unveiled key parts of their policy agendas for 2016.
Read more
Washington Outlook for 2016
January 20, 2016 | Advisory
Welcome to 2016 and our annual look at what’s in store for the United States Congress in the coming year. Here you will find a preview of the US legislative agenda as well as a look at the Obama Administration’s regulatory plans.
Read more
Governor Baker Announces Mid-Year Budget Cuts
January 11, 2016 | Alert | By Julie Cox, Daniel Connelly, Maxwell Fathy
On Friday, January 8, Governor Charlie Baker ordered $49 million in emergency spending cuts aimed at erasing a projected state budget shortfall. In a letter to state lawmakers, Baker said his administration had identified a $320 million gap between projected spending and revenues through the end of the fiscal year in July.
Read more
As Deadline for Expiration Approaches, Congressional Action Likely
December 7, 2015 | Alert | By Alexander Hecht, R. Neal Martin
Now just days away from the December 11th expiration of a short-term Continuing Resolution (CR) that has been funding federal activities since the start of the current fiscal year on October 1st, Congress is feverishly working to reach agreement on a long-term Omnibus spending bill that will fund the federal government through the remainder of the fiscal year.
Read more
FDA Invites Genome Scientists to Come Play in the precision FDA “Sandbox”
November 13, 2015 | Alert | By Joanne Hawana
On November 12th and 13th, the Food and Drug Administration hosted genome scientists from across the nation at its campus in White Oak, Maryland.
Read more
Recent Developments in Massachusetts Health Policy
October 23, 2015 | Alert | By Julie Cox, Sasha Dudding, Stephen Weiner
Building on the momentum of early October hearings on the state’s growing health care expenditures, the Health Policy Commission (HPC), the Joint Committee on Health Care Financing, Governor Charlie Baker, and others spent the past two weeks crafting new policies for the industry and its consumers.
Read more
Massachusetts Legislature Takes Action on Opioid Crisis
October 7, 2015 | Alert | By Julie Cox, Sasha Dudding
Amid a recent surge in opioid-related deaths in Massachusetts, with over 1,200 accidental deadly overdoses last year, the Senate passed legislation on October 1st that is designed to fight the epidemic on various fronts.
Read more
EB-5 Regional Center Program to Get Short-Term Reprieve with Passage of Continuing Resolution
September 30, 2015 | Alert | By Alexander Hecht, R. Neal Martin, Douglas Hauer
Coinciding with the end of the current fiscal year, the EB-5 regional center program is set to expire today but will get a temporary reprieve with expected final passage of a Continuing Resolution (CR) that will fund the government through December 11 and also temporarily extend the regional center program through that same date.
Read more
Massachusetts Legislature Ends Active July with Budget Overrides
August 5, 2015 | Alert | By George Atanasov, Julie Cox, Max Samels
After a busy final few weeks of activity, the Massachusetts Legislature departed for its summer recess with a new budget and progress on several priority policy issues. In addition to overriding $97 million in Governor Baker’s vetoes, Boston lawmakers considered tax, public records, energy, healthcare, and labor issues.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology